The role of MCPs in mediating PCCs has been demonstrated by one of the studies, which showed an association between plasma OPN levels and the persistence of severe exertional dyspnea and poor quality of life in COVID-19 patients who required hospitalization [25]. The gene discussed is SPP1; the disease is COVID-19.